Provectus Biopharmaceuticals (PVCT) Asset Utilization Ratio (2021 - 2026)
Provectus Biopharmaceuticals' Asset Utilization Ratio was 0.60 in Q4 2025, down 11.9% from 0.68 a year earlier and down 2.0% from the prior quarter.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Provectus Biopharmaceuticals came in at 0.39, down 21.5% from FY2024.
- In earlier years, Asset Utilization Ratio was 0.50 in FY2024 (+57.1%), 0.32 in FY2023 (-10.2%) and 0.36 in FY2022.
- The Q4 2025 figure marks the lowest quarterly Asset Utilization Ratio since Q1 2024.
- Compared with a year earlier, Asset Utilization Ratio has declined for three straight quarters, with growth averaging 35.9% over the last eight quarters.
- The best year-over-year quarter for Asset Utilization Ratio over five years was Q3 2024 (growth of 145.1%); the worst was Q3 2025 (a decline of 29.7%).
- Per Business Quant data, PVCT's Asset Utilization Ratio in the three quarters before Q4 2025 was 0.61 (Q3 2025), 0.66 (Q2 2025) and 0.79 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 0.31 |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Dec 31, 2025 | 0.60 |
| Sep 30, 2025 | 0.61 |
| Jun 30, 2025 | 0.66 |
| Mar 31, 2025 | 0.79 |
| Dec 31, 2024 | 0.68 |
| Sep 30, 2024 | 0.87 |
| Jun 30, 2024 | 0.71 |
| Mar 31, 2024 | 0.47 |
| Dec 31, 2023 | 0.36 |
| Sep 30, 2023 | 0.36 |
| Jun 30, 2023 | 0.50 |
| Mar 31, 2023 | 0.54 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.36 |
| Jun 30, 2022 | 0.19 |
| Mar 31, 2022 | -0.09 |
| Dec 31, 2021 | -0.47 |
API Access
Provectus Biopharmaceuticals Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();